November 2020 PMID 33030710

Clascoterone: First Approval.

Sohita Dhillon

Mentions

4
Peak: 2 in Jun 2021
across 2 sources since Jun 2021

Extended reach

180,108
potential audience

Total likes

865

Video views

50,462

Mentions per month

Jun 2021 – Dec 2023

Where it's discussed

  • X / Twitter2 posts
  • YouTube2 videos

AI synopsis

What people are saying

The overall tone reveals strong support and enthusiasm, with users emphasizing the importance of Clascoterone’s approval for acne and hair loss treatments. Words like 'promising' and 'game changer' show excitement, while references to ongoing studies reflect genuine interest in future developments and real-world implications.

AgreementModerate agreement

Most discussions reflect support or positive recognition of the publication's significance, indicating agreement with its findings and implications.

InterestHigh interest

Many social discussions show a high level of curiosity and enthusiasm about the new medication and its potential uses, suggesting strong interest.

EngagementHigh engagement

Users are actively commenting, sharing insights, and emphasizing the importance of this approval, demonstrating deep engagement with the topic.

ImpactModerate impact

The discussions highlight the potential for this approval to influence treatment options for skin conditions, indicating a notable impact.

Abstract in brief

  • Clascoterone (Winlevi) is a topical medication developed by Cassiopea to treat androgen-dependent skin conditions like acne and hair loss by blocking androgen receptors in the skin.
  • It works by competing with the hormone dihydrotestosterone for binding to androgen receptors, which helps reduce the signals that cause acne.
  • In August 2020, clascoterone cream was approved in the USA for treating acne in patients 12 years and older, and further studies are ongoing for its use in treating hair loss.]

Top posts

Most liked on X and Bluesky
静岡皮膚科(2024年3月開業/静岡駅徒歩3分)院長 江畑慧
@shizuoka_doctor · X

<参考文献> https://t.co/Jm3uE6VL76 https://t.co/SCTiAcAres https://t.co/GV8duGpwct https://t.co/SRz0p9LxmX https://t.co/YsLc4HLS3V https://t.co/0DACCH7UuZ https://t.co/y6fZWzCs0F https://t.co/IPKwti0IBG https://t.co/BDFxFcTYFq

Dec 1, 2021 · 13 likes · 1 share · 129,250 followers View post →
Mohsenoo
@mohsenooooo · X

مقایسه جالبی بین تمامی درمان‌های رایج ریزش مو: https://t.co/CGDf6vl0uH

Jun 14, 2021 · 395 followers View post →

All mentions

静岡皮膚科(2024年3月開業/静岡駅徒歩3分)院長 江畑慧
@shizuoka_doctor · X

<参考文献> https://t.co/Jm3uE6VL76 https://t.co/SCTiAcAres https://t.co/GV8duGpwct https://t.co/SRz0p9LxmX https://t.co/YsLc4HLS3V https://t.co/0DACCH7UuZ https://t.co/y6fZWzCs0F https://t.co/IPKwti0IBG https://t.co/BDFxFcTYFq

Dec 1, 2021 · 13 likes · 1 share · 129,250 followers View post →
Mohsenoo
@mohsenooooo · X

مقایسه جالبی بین تمامی درمان‌های رایج ریزش مو: https://t.co/CGDf6vl0uH

Jun 14, 2021 · 395 followers View post →